Vedolizumab as a Novel Treatment for Refractory Collagenous Colitis: A Case Report

Vedolizumab as a Novel Treatment for Refractory Collagenous Colitis: A Case Report American Journal of Gastroenterology 113, 632 (April 2018). doi:10.1038/ajg.2018.7 Authors: Kelly C Cushing, Mari Mino-Kenudson, John Garber, Paul Lochhead & Hamed Khalili
Source: The American Journal of Gastroenterology - Category: Gastroenterology Authors: Source Type: research
More News: Gastroenterology